Not applicableStudy completedNCT05505175What this trial is testingOutcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBCWho this might be right forBreast CancerBreast Carcinoma Pfizer 121
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Not applicableEnded earlyNCT00898781What this trial is testingStudy of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic CancerWho this might be right forBreast CancerColorectal CancerOvarian Cancer+1 more Mayo Clinic 80
Testing effectiveness (Phase 2)Study completedNCT00368875What this trial is testingPhase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerWho this might be right forMale Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)UnknownNCT03044730What this trial is testingPembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by SurgeryWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+7 more Northwestern University 30